Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults

Luca Cantarini, F. Iacoponi, O. M. Lucherini, L. Obici, M. G. Brizi, R. Cimaz, D. Rigante, M. Benucci, G. D. Sebastiani, A. Brucato, L. Sabadini, G. Simonini, T. Giani, F. Laghi Pasini, C. T. Baldari, F. Bellisai, G. Valentini, S. Bombardieri, G. Paolazzi, M. Galeazzi

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Most autoinflammatory disorders typically come out in the pediatric population, although a limited number of patients may experience disease onset during adulthood. To date, a late disease onset has been described only in familial Mediterranean fever, caused by mutations in the MEFV gene, and in tumor necrosis factor receptor-associated periodic syndrome, caused by mutations in the TNFRSF1A gene. The relative rarity and lack of information on adult-onset autoinflammatory diseases make it likely that mutations will be found in an even smaller percentage of cases. With the aim of improving the genetic diagnosis in adults with suspected autoinflammatory disorders, we recently identified a set of variables related to the probability of detecting gene mutations in MEFV and TNFRSFlA and, in addition, we have also proposed a diagnostic score for identifying those patients at high risk of carrying mutations in these genes. In the present study we evaluated the preliminary score sensitivity and specificity on a wider number of patients in order to validate the goodness of fit of the model. Two hundred and nineteen consecutive patients with a clinical history of periodic fever attacks were screened for mutations in MEFV and TNFRSF1A genes; detailed information about family/personal history and clinical manifestations were also collected. For the validation of the score we considered data both from the 110 patients used to build the preliminary diagnostic score and from the additional 219 patients enrolled in the present study, for a total number of 329 patients. Early age at disease onset, positive family history for recurrent fever episodes, thoracic pain, abdominal pain and skin rash, which are the variables that had previously been shown to be significantly associated with a positive genetic test result (12), were used for validation. On univariate analysis the associations with a positive genetic test were: age at onset (odds ratio [OR] 0.43, p=0.003), positive family history for recurrent fever episodes (OR 5.81, p

Original languageEnglish
Pages (from-to)695-702
Number of pages8
JournalInternational Journal of Immunopathology and Pharmacology
Volume24
Issue number3
Publication statusPublished - Jul 2011

Fingerprint

Mutation
Fever
Genes
Age of Onset
Odds Ratio
Familial Mediterranean Fever
Exanthema
Chest Pain
Abdominal Pain
Pediatrics
Sensitivity and Specificity
Population

Keywords

  • Autoinflammatory disorders
  • Diagnostic criteria
  • Familial mediterranean fever (FMF)
  • Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Cantarini, L., Iacoponi, F., Lucherini, O. M., Obici, L., Brizi, M. G., Cimaz, R., ... Galeazzi, M. (2011). Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. International Journal of Immunopathology and Pharmacology, 24(3), 695-702.

Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. / Cantarini, Luca; Iacoponi, F.; Lucherini, O. M.; Obici, L.; Brizi, M. G.; Cimaz, R.; Rigante, D.; Benucci, M.; Sebastiani, G. D.; Brucato, A.; Sabadini, L.; Simonini, G.; Giani, T.; Laghi Pasini, F.; Baldari, C. T.; Bellisai, F.; Valentini, G.; Bombardieri, S.; Paolazzi, G.; Galeazzi, M.

In: International Journal of Immunopathology and Pharmacology, Vol. 24, No. 3, 07.2011, p. 695-702.

Research output: Contribution to journalArticle

Cantarini, L, Iacoponi, F, Lucherini, OM, Obici, L, Brizi, MG, Cimaz, R, Rigante, D, Benucci, M, Sebastiani, GD, Brucato, A, Sabadini, L, Simonini, G, Giani, T, Laghi Pasini, F, Baldari, CT, Bellisai, F, Valentini, G, Bombardieri, S, Paolazzi, G & Galeazzi, M 2011, 'Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults', International Journal of Immunopathology and Pharmacology, vol. 24, no. 3, pp. 695-702.
Cantarini, Luca ; Iacoponi, F. ; Lucherini, O. M. ; Obici, L. ; Brizi, M. G. ; Cimaz, R. ; Rigante, D. ; Benucci, M. ; Sebastiani, G. D. ; Brucato, A. ; Sabadini, L. ; Simonini, G. ; Giani, T. ; Laghi Pasini, F. ; Baldari, C. T. ; Bellisai, F. ; Valentini, G. ; Bombardieri, S. ; Paolazzi, G. ; Galeazzi, M. / Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. In: International Journal of Immunopathology and Pharmacology. 2011 ; Vol. 24, No. 3. pp. 695-702.
@article{e2a82000a5e649c7930e95c9cce7c219,
title = "Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults",
abstract = "Most autoinflammatory disorders typically come out in the pediatric population, although a limited number of patients may experience disease onset during adulthood. To date, a late disease onset has been described only in familial Mediterranean fever, caused by mutations in the MEFV gene, and in tumor necrosis factor receptor-associated periodic syndrome, caused by mutations in the TNFRSF1A gene. The relative rarity and lack of information on adult-onset autoinflammatory diseases make it likely that mutations will be found in an even smaller percentage of cases. With the aim of improving the genetic diagnosis in adults with suspected autoinflammatory disorders, we recently identified a set of variables related to the probability of detecting gene mutations in MEFV and TNFRSFlA and, in addition, we have also proposed a diagnostic score for identifying those patients at high risk of carrying mutations in these genes. In the present study we evaluated the preliminary score sensitivity and specificity on a wider number of patients in order to validate the goodness of fit of the model. Two hundred and nineteen consecutive patients with a clinical history of periodic fever attacks were screened for mutations in MEFV and TNFRSF1A genes; detailed information about family/personal history and clinical manifestations were also collected. For the validation of the score we considered data both from the 110 patients used to build the preliminary diagnostic score and from the additional 219 patients enrolled in the present study, for a total number of 329 patients. Early age at disease onset, positive family history for recurrent fever episodes, thoracic pain, abdominal pain and skin rash, which are the variables that had previously been shown to be significantly associated with a positive genetic test result (12), were used for validation. On univariate analysis the associations with a positive genetic test were: age at onset (odds ratio [OR] 0.43, p=0.003), positive family history for recurrent fever episodes (OR 5.81, p",
keywords = "Autoinflammatory disorders, Diagnostic criteria, Familial mediterranean fever (FMF), Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)",
author = "Luca Cantarini and F. Iacoponi and Lucherini, {O. M.} and L. Obici and Brizi, {M. G.} and R. Cimaz and D. Rigante and M. Benucci and Sebastiani, {G. D.} and A. Brucato and L. Sabadini and G. Simonini and T. Giani and {Laghi Pasini}, F. and Baldari, {C. T.} and F. Bellisai and G. Valentini and S. Bombardieri and G. Paolazzi and M. Galeazzi",
year = "2011",
month = "7",
language = "English",
volume = "24",
pages = "695--702",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "3",

}

TY - JOUR

T1 - Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults

AU - Cantarini, Luca

AU - Iacoponi, F.

AU - Lucherini, O. M.

AU - Obici, L.

AU - Brizi, M. G.

AU - Cimaz, R.

AU - Rigante, D.

AU - Benucci, M.

AU - Sebastiani, G. D.

AU - Brucato, A.

AU - Sabadini, L.

AU - Simonini, G.

AU - Giani, T.

AU - Laghi Pasini, F.

AU - Baldari, C. T.

AU - Bellisai, F.

AU - Valentini, G.

AU - Bombardieri, S.

AU - Paolazzi, G.

AU - Galeazzi, M.

PY - 2011/7

Y1 - 2011/7

N2 - Most autoinflammatory disorders typically come out in the pediatric population, although a limited number of patients may experience disease onset during adulthood. To date, a late disease onset has been described only in familial Mediterranean fever, caused by mutations in the MEFV gene, and in tumor necrosis factor receptor-associated periodic syndrome, caused by mutations in the TNFRSF1A gene. The relative rarity and lack of information on adult-onset autoinflammatory diseases make it likely that mutations will be found in an even smaller percentage of cases. With the aim of improving the genetic diagnosis in adults with suspected autoinflammatory disorders, we recently identified a set of variables related to the probability of detecting gene mutations in MEFV and TNFRSFlA and, in addition, we have also proposed a diagnostic score for identifying those patients at high risk of carrying mutations in these genes. In the present study we evaluated the preliminary score sensitivity and specificity on a wider number of patients in order to validate the goodness of fit of the model. Two hundred and nineteen consecutive patients with a clinical history of periodic fever attacks were screened for mutations in MEFV and TNFRSF1A genes; detailed information about family/personal history and clinical manifestations were also collected. For the validation of the score we considered data both from the 110 patients used to build the preliminary diagnostic score and from the additional 219 patients enrolled in the present study, for a total number of 329 patients. Early age at disease onset, positive family history for recurrent fever episodes, thoracic pain, abdominal pain and skin rash, which are the variables that had previously been shown to be significantly associated with a positive genetic test result (12), were used for validation. On univariate analysis the associations with a positive genetic test were: age at onset (odds ratio [OR] 0.43, p=0.003), positive family history for recurrent fever episodes (OR 5.81, p

AB - Most autoinflammatory disorders typically come out in the pediatric population, although a limited number of patients may experience disease onset during adulthood. To date, a late disease onset has been described only in familial Mediterranean fever, caused by mutations in the MEFV gene, and in tumor necrosis factor receptor-associated periodic syndrome, caused by mutations in the TNFRSF1A gene. The relative rarity and lack of information on adult-onset autoinflammatory diseases make it likely that mutations will be found in an even smaller percentage of cases. With the aim of improving the genetic diagnosis in adults with suspected autoinflammatory disorders, we recently identified a set of variables related to the probability of detecting gene mutations in MEFV and TNFRSFlA and, in addition, we have also proposed a diagnostic score for identifying those patients at high risk of carrying mutations in these genes. In the present study we evaluated the preliminary score sensitivity and specificity on a wider number of patients in order to validate the goodness of fit of the model. Two hundred and nineteen consecutive patients with a clinical history of periodic fever attacks were screened for mutations in MEFV and TNFRSF1A genes; detailed information about family/personal history and clinical manifestations were also collected. For the validation of the score we considered data both from the 110 patients used to build the preliminary diagnostic score and from the additional 219 patients enrolled in the present study, for a total number of 329 patients. Early age at disease onset, positive family history for recurrent fever episodes, thoracic pain, abdominal pain and skin rash, which are the variables that had previously been shown to be significantly associated with a positive genetic test result (12), were used for validation. On univariate analysis the associations with a positive genetic test were: age at onset (odds ratio [OR] 0.43, p=0.003), positive family history for recurrent fever episodes (OR 5.81, p

KW - Autoinflammatory disorders

KW - Diagnostic criteria

KW - Familial mediterranean fever (FMF)

KW - Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)

UR - http://www.scopus.com/inward/record.url?scp=80055113996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055113996&partnerID=8YFLogxK

M3 - Article

C2 - 21978701

AN - SCOPUS:80055113996

VL - 24

SP - 695

EP - 702

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 3

ER -